Orlando, FL 的 重度憂鬱症 臨床試驗
19 項針對 重度憂鬱症 的研究正在 Orlando（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
招募中2 期
- Clinical Neuroscience Solutions, Inc., Orlando
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- Accel Research Sites - Maitland, Maitland · 距離 6 英里
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- Charter Research, Orlando
- K2 Medical Research (Maitland), Maitland · 距離 6 英里
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- Charter Research - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · 距離 6 英里
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- Nova Psychiatry INC, Orlando
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- Clinical Neuroscience Solutions Inc. - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · 距離 6 英里
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
招募中2 期
- Seaport Investigator Site, Orlando
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Orlando
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距離 6 英里
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Clinical Neuroscience Solutions, Inc., Orlando
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Clinical Neuroscience Solutions, Inc., Orlando
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距離 6 英里
- Neurocrine Clinical Site, Maitland · 距離 6 英里
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orlando
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距離 6 英里
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
招募中
- AdventHealth Neuroscience Institute, Orlando
Study of ALTO-300 in MDD
招募中2 期
- Site 159, Clermont · 距離 24 英里
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
招募中4 期
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
其他城市的 重度憂鬱症 試驗
- New York City, NY36 項研究
- Boston, MA31 項研究
- Atlanta, GA25 項研究
- Philadelphia, PA23 項研究
- Miami, FL18 項研究
- Chicago, IL17 項研究
- Tampa, FL17 項研究
- San Diego, CA16 項研究
- Houston, TX16 項研究
- Little Rock, AR14 項研究
- Austin, TX13 項研究
- Las Vegas, NV13 項研究
Orlando 的其他研究
- 非小細胞肺癌44 項研究
- 肥胖症32 項研究
- 轉移性癌症29 項研究
- 過重27 項研究
- 阿茲海默症25 項研究
- 第二型糖尿病25 項研究
- 癌症（所有類型）24 項研究
- 乳癌23 項研究
- 卵巢癌22 項研究
- 潰瘍性結腸炎22 項研究
- 肺癌21 項研究
- 大腸直腸癌19 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。